Hematuria risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hematuria}}
{{Hematuria}}
{{SCC}} {{AE}}{{VSKP}}
{{CMG}} ; {{AE}} {{SCC}} {{Adnan Ezici}} {{VSKP}}


== Overview ==
== Overview ==
 
Common risk factors in the development of hematuria include recent infection, strenuous exercise or normal exercise under extreme circumstances, males > 50 years old, and female sex (due to the higher prevalence of urinary tract infection). Common risk factors for urinary tract malignancy in patients with hematuria include age >35, [[analgesic]] abuse, exposure to chemicals or dyes (benzenes or [[aromatic amines]]), male sex, and smoking history.
==Risk Factors==
==Risk Factors==
People of all age groups, including children, can have hematuria. Certain factors increase the chance of hematuria:
Common risk factors in the development of hematuria include:
*Recent infection: Post-infectious [[glomerulonephritis]], [[IgA nephropathy]]
*Recent [[infection]]: Post-infectious [[glomerulonephritis]], [[IgA nephropathy]]
*Exercise: Long distance runners are prone to exercise induced urinary bleeding.  
*Exercise: Long distance runners are prone to exercise-induced urinary bleeding.  
*Age: Males older than 50 years have an enlarged prostate that can cause hematuria.
*Age: Males older than 50 years have an enlarged [[prostate]] that can cause hematuria.
*Sex: 50% of all women suffer from [[Urinary tract infection|urinary tract infection]]s at least once in their life time, which can also cause urinary bleeding.
*Sex: 50% of all women suffer from [[Urinary tract infection|urinary tract infection]]s at least once in their lifetime, which can also cause urinary bleeding.
Common risk factors for urinary tract malignancy in patients with hematuria:<ref name="pmid24364522">Sharp VJ, Barnes KT, Erickson BA (2013) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=24364522 Assessment of asymptomatic microscopic hematuria in adults.] ''Am Fam Physician'' 88 (11):747-54. PMID: [https://pubmed.gov/24364522 24364522]</ref>
*History of any of the following:
** Chronic indwelling foreign body
** Chronic [[urinary tract infection]]
** Exposure to known [[Carcinogenic|carcinogenic agents]] or alkylating chemotherapeutic agents
** Gross hematuria
** Irritative voiding symptoms
** Pelvic irradiation
** Urologic disorder or disease
Common risk factors for urinary tract malignancy in patients with hematuria:<ref name="pmid24364522">Sharp VJ, Barnes KT, Erickson BA (2013) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=24364522 Assessment of asymptomatic microscopic hematuria in adults.] ''Am Fam Physician'' 88 (11):747-54. PMID: [https://pubmed.gov/24364522 24364522]</ref><ref name="pmid27636220">{{cite journal |vauthors=Richter LA, Lippmann QK, Jallad K, Lucas J, Yeung J, Dune T, Mellano E, Weissbart S, Mete M, Kim JH, Gutman R |title=Risk Factors for Microscopic Hematuria in Women |journal=Female Pelvic Med Reconstr Surg |volume=22 |issue=6 |pages=486–490 |date=2016 |pmid=27636220 |doi=10.1097/SPV.0000000000000321 |url=}}</ref><ref name="pmid23538242">{{cite journal |vauthors=Jackson RE, Casanova NF, Wallner LP, Dunn RL, Hedgepeth RC, Faerber GJ, Wei JT |title=Risk factors for delayed hematuria following photoselective vaporization of the prostate |journal=J. Urol. |volume=190 |issue=3 |pages=903–8 |date=September 2013 |pmid=23538242 |doi=10.1016/j.juro.2013.03.070 |url=}}</ref>
* Age older than 35 years
* Age older than 35 years
* Analgesic abuse
* [[Analgesic]] abuse
* Exposure to chemicals or dyes (benzenes or aromatic amines)
* Exposure to chemicals or dyes (benzenes or [[aromatic amines]])
* Male sex
* Male sex
* Past or current smoking
* Past or current smoking
* History of any of the following:
History of any of the following:
* Chronic indwelling foreign body
* Chronic indwelling foreign body
* Chronic urinary tract infection
* Chronic [[urinary tract infection]]
* Exposure to known carcinogenic agents or alkylating chemotherapeutic agents
* Exposure to known [[Carcinogenic|carcinogenic agents]] or alkylating chemotherapeutic agents
* Gross hematuria
* Gross hematuria
* Irritative voiding symptoms
* Irritative voiding symptoms
Line 28: Line 36:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
<references />
[[Category:Nephrology]]
[[Category:Nephrology]]
[[Category:Urology]]
[[Category:Urology]]
Line 33: Line 43:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Needs overview]]
[[Category:Needs overview]]
[[Category:Primary care]]
<references />

Latest revision as of 16:03, 26 September 2021

Hematuria Microchapters

Home

Patient Information

Overview

Definition

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hematuria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hematuria risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hematuria risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hematuria risk factors

CDC on Hematuria risk factors

Hematuria risk factors in the news

Blogs on Hematuria risk factors

Directions to Hospitals Treating Hematuria

Risk calculators and risk factors for Hematuria risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Steven C. Campbell, M.D., Ph.D. Adnan Ezici, M.D[2] Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [3]

Overview

Common risk factors in the development of hematuria include recent infection, strenuous exercise or normal exercise under extreme circumstances, males > 50 years old, and female sex (due to the higher prevalence of urinary tract infection). Common risk factors for urinary tract malignancy in patients with hematuria include age >35, analgesic abuse, exposure to chemicals or dyes (benzenes or aromatic amines), male sex, and smoking history.

Risk Factors

Common risk factors in the development of hematuria include:

  • Recent infection: Post-infectious glomerulonephritis, IgA nephropathy
  • Exercise: Long distance runners are prone to exercise-induced urinary bleeding.
  • Age: Males older than 50 years have an enlarged prostate that can cause hematuria.
  • Sex: 50% of all women suffer from urinary tract infections at least once in their lifetime, which can also cause urinary bleeding.
  • History of any of the following:
    • Chronic indwelling foreign body
    • Chronic urinary tract infection
    • Exposure to known carcinogenic agents or alkylating chemotherapeutic agents
    • Gross hematuria
    • Irritative voiding symptoms
    • Pelvic irradiation
    • Urologic disorder or disease

Common risk factors for urinary tract malignancy in patients with hematuria:[1][2][3]

  • Age older than 35 years
  • Analgesic abuse
  • Exposure to chemicals or dyes (benzenes or aromatic amines)
  • Male sex
  • Past or current smoking

History of any of the following:

  • Chronic indwelling foreign body
  • Chronic urinary tract infection
  • Exposure to known carcinogenic agents or alkylating chemotherapeutic agents
  • Gross hematuria
  • Irritative voiding symptoms
  • Pelvic irradiation
  • Urologic disorder or disease

References

  1. Sharp VJ, Barnes KT, Erickson BA (2013) Assessment of asymptomatic microscopic hematuria in adults. Am Fam Physician 88 (11):747-54. PMID: 24364522
  2. Richter LA, Lippmann QK, Jallad K, Lucas J, Yeung J, Dune T, Mellano E, Weissbart S, Mete M, Kim JH, Gutman R (2016). "Risk Factors for Microscopic Hematuria in Women". Female Pelvic Med Reconstr Surg. 22 (6): 486–490. doi:10.1097/SPV.0000000000000321. PMID 27636220.
  3. Jackson RE, Casanova NF, Wallner LP, Dunn RL, Hedgepeth RC, Faerber GJ, Wei JT (September 2013). "Risk factors for delayed hematuria following photoselective vaporization of the prostate". J. Urol. 190 (3): 903–8. doi:10.1016/j.juro.2013.03.070. PMID 23538242.